ArticleThe Journal of biological chemistry2013

Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.

Dong-Rong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.